Five-year effectiveness of low-dose-rate brachytherapy: comparisons with nomogram predictions in patients with non-metastatic prostate cancer presenting significant control of intr... von Zimmermann, Jörg S, Osieka, Rudolf, Bruns, Thorsten, Hollberg, Helge, Wiechmann, Bastian, Netzbandt, Olaf, Sablotny, Jörg, Malade, Michael, Heitz, Matthias, Bernhardt, Fritz, Tiemann, Jörg, Wilkens, Marc, Brüske, Tom, Welker, Utz, Heinemann, Volker, Zimmermann, Petra, de la Maza, Salvador Fernandez, Pfeiffer, Dietrich, Tauber, Prof Roland, Thomas, Dorothea, Moustakis, Christos

Volltext

Longterm Results 60 Months after LDR-Brachytherapy +-EBRT+-ADT for Non-Metastasized Prostate Cancer with Low, Intermediate and High Progression Risk - Evaluation for Various Risk G... von Zimmermann, Joerg S., MD, Moustakis, Christos, PhD, Bruns, Thorsten, MD, Brüske, Tom, MD, Constantine, Emil, MD, Ganama, Anwar, MD, Heinemann, Volker, MD, Heitz, Matthias, MD, Hollberg, Helge, MD, Netzbandt, Olaf, MD, Osieka, Rudolf, MD, Sablotny, Joerg, MD, Welker, Utz, MD, Wiechmann, Bastian, MD, Wilkens, Marcus, MD, Tiemann, Jörg, MD, Zimmermann, Petra, MD, Thomas, Dorothea, PhD, Kurzidem, Marcus, MD, Tauber, Roland, MD, Fernandez de la Maza, Salvador, MD

Volltext

Are Predictions from Partin Tables and Kattan Nomograms Useful for the Assessment of the Oncological Outcomes after LDR Brachytherapy +-EBRT +- ADT in Localized (N0M0) Prostate Can... von Zimmermann, Joerg S., MD, Moustakis, Christos, PhD, Thomas, Dorothea, PhD, Zimmermann, Petra, MD, Sablotny, Joerg, MD, Osieka, Rudolf, MD, Welker, Utz, MD, Ganama, Anwar, MD, Bruns, Thorsten, MD, Brüske, Tom, MD, Constantine, Emil, MD, Heinemann, Volker, MD, Heitz, Matthias, MD, Hollberg, Helge, MD, Netzbandt, Olaf, MD, Wiechmann, Bastian, MD, Wilkens, Marc, MD, Tiemann, Jörg, MD, Kurzidem, Marcus, MD, Tauber, Roland, MD, Fernandez de la Maza, Salvador, MD

Volltext